4.5 Article

Serum levels of 4-hydroxynonenal adducts and responding autoantibodies correlate with the pathogenesis from hyperglycemia to Alzheimer's disease

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Medicine, General & Internal

Donanemab in Early Alzheimer's Disease

Mark A. Mintun et al.

Summary: In this study, donanemab showed improved composite scores for cognition and daily living activities compared to placebo in patients with early Alzheimer's disease at 76 weeks, although secondary outcomes varied. Longer and larger trials are needed to further explore the efficacy and safety of donanemab in Alzheimer's disease.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Letter Multidisciplinary Sciences

Alzheimer's drugs: Does reducing amyloid work?

Madhav Thambisetty et al.

SCIENCE (2021)

Article Clinical Neurology

A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer's disease with lecanemab, an anti-Aβ protofibril antibody

Chad J. Swanson et al.

Summary: BAN2401-G000-201 trial aimed to establish the effective dose and observe the treatment effect. While not meeting the primary endpoint at 12 months, results at 18 months demonstrated reduction in brain amyloid and improvement across multiple clinical and biomarker endpoints.

ALZHEIMERS RESEARCH & THERAPY (2021)

Article Biochemistry & Molecular Biology

A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer's disease

Stephen Salloway et al.

Summary: Results from the phase 2/3 clinical trial of gantenerumab or solanezumab in dominantly inherited Alzheimer's disease show no cognitive benefits despite reduced amyloid plaques and other key biomarkers with gantenerumab. Solanezumab did not show cognitive benefits and even led to greater decline on some measures, with no benefits on downstream biomarkers. Gantenerumab significantly reduced amyloid plaques and some biomarkers but did not slow cognitive decline in symptomatic DIAD patients.

NATURE MEDICINE (2021)

Editorial Material Multidisciplinary Sciences

Treatments for Alzheimer's disease emerge

Dennis J. Selkoe

SCIENCE (2021)

Editorial Material Multidisciplinary Sciences

Phenotyping Alzheimer's disease with blood tests

Kaj Blennow

SCIENCE (2021)

Article Multidisciplinary Sciences

An evaluation of the self-assembly enhancing properties of cell-derived hexameric amyloid-β

Devkee M. Vadukul et al.

Summary: Alzheimer's disease is characterized by the deposition of amyloid plaques composed primarily of the amyloidogenic A beta peptide. A beta 42 isoform, particularly neurotoxic, is released from Cleavage of C99 by gamma-secretase. The misfolding of A beta leads to amyloid fibril formation, requiring a critical nucleus for self-assembly.

SCIENTIFIC REPORTS (2021)

Article Chemistry, Medicinal

Cognitive dysfunction: A growing link between diabetes and Alzheimer's disease

Kavya Jash et al.

DRUG DEVELOPMENT RESEARCH (2020)

Article Medical Laboratory Technology

Reduction of AHI1 in the serum of Taiwanese with probable Alzheimer's disease

Jau-Jiuan Sheu et al.

CLINICAL BIOCHEMISTRY (2020)

Article Neurosciences

Alzheimer's Disease and Diabetes: Insulin Signaling as the Bridge Linking Two Pathologies

Jonathan Chang-Cheng Shieh et al.

MOLECULAR NEUROBIOLOGY (2020)

Review Biochemistry & Molecular Biology

Prevention of Cognitive Decline in Alzheimer's Disease by Novel Antioxidative Supplements

Koh Tadokoro et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Biochemistry & Molecular Biology

The Functional Roles and Applications of Immunoglobulins in Neurodegenerative Disease

Kyu-Young Sim et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Cell Biology

Clinical trials of new drugs for Alzheimer disease

Li-Kai Huang et al.

JOURNAL OF BIOMEDICAL SCIENCE (2020)

Article Biochemistry & Molecular Biology

ALDH 2 conferred neuroprotection on cerebral ischemic injury by alleviating mitochondria-related apoptosis through JNK/caspase-3 signing pathway

Pingping Xia et al.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2020)

Review Biochemistry & Molecular Biology

HDL from an Alzheimer's disease perspective

Emily B. Button et al.

CURRENT OPINION IN LIPIDOLOGY (2019)

Review Cell Biology

4-Hydroxy-Trans-2-Nonenal in the Regulation of Anti-Oxidative and Pro-Inflammatory Signaling Pathways

Himangshu Sonowal et al.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2019)

Article Clinical Neurology

Evidence for brain glucose dysregulation in Alzheimer's disease

Yang An et al.

ALZHEIMERS & DEMENTIA (2018)

Review Biochemistry & Molecular Biology

Lipid Peroxidation-Derived Aldehydes, 4-Hydroxynonenal and Malondialdehyde in Aging-Related Disorders

Giuseppina Barrera et al.

ANTIOXIDANTS (2018)

Review Biochemistry & Molecular Biology

Role of 4-hydroxy-2-nonenal (HNE) in the pathogenesis of alzheimer disease and other selected age-related neurodegenerative disorders

Fabio Di Domenico et al.

FREE RADICAL BIOLOGY AND MEDICINE (2017)

Review Clinical Neurology

A systemic view of Alzheimer disease - insights from amyloid-β metabolism beyond the brain

Jun Wang et al.

NATURE REVIEWS NEUROLOGY (2017)

Review Chemistry, Multidisciplinary

Amyloid beta: structure, biology and structure-based therapeutic development

Guo-fang Chen et al.

ACTA PHARMACOLOGICA SINICA (2017)

Article Multidisciplinary Sciences

The antibody aducanumab reduces Aβ plaques in Alzheimer's disease

Jeff Sevigny et al.

NATURE (2016)

Review Biochemistry & Molecular Biology

Diabetes Mellitus Induces Alzheimer's Disease Pathology: Histopathological Evidence from Animal Models

Nobuyuki Kimura

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)

Article Neurosciences

Oxidative stress and lipid peroxidation are upstream of amyloid pathology

Muriel Arimon et al.

NEUROBIOLOGY OF DISEASE (2015)

Article Biochemical Research Methods

The reactivity of human serum albumin towards trans-4-hydroxy-2-nonenal

Qingyuan Liu et al.

JOURNAL OF MASS SPECTROMETRY (2012)

Article Endocrinology & Metabolism

HDL as a Biomarker, Potential Therapeutic Target, and Therapy

Mohamad Navab et al.

DIABETES (2009)